Cotrimoxazole/efavirenz/lamivudine/tenofovir-disoproxil-fumarateRenal impairment, decline in renal function and non-diabetic glycosuria: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1777卷 / 1期

关键词：

D O I：

10.1007/s40278-019-70663-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：80 / 80

相关论文

共 7 条

[1] Tenofovir-disoproxil-fumarateRenal tubular dysfunction: 3 case reports
Reactions Weekly, 2019, 1766 (1) : 278 - 278
[2] Efavirenz/lamivudine/tenofovir disoproxil fumarateVarious toxicities: 3 case reports
Reactions Weekly, 2019, 1783 (1) : 113 - 113
[3] Efavirenz/lamivudine/tenofovir disoproxil fumarateVirologic failure: 3 case reports
Reactions Weekly, 2023, 1940 (1) : 176 - 176
[4] Tenofovir disoproxil fumarateFanconi syndrome and renal impairment: 3 case reports
Reactions Weekly, 2011, 1368 (1) : 37 - 37
[5] Efavirenz/lamivudine/tenofovir-disoproxil-fumarateVirological failure due to acquired resistance mutations: 3 case reports
Reactions Weekly, 2021, 1865 (1) : 181 - 181
[6] Cabotegravir/emtricitabine/tenofovir-disoproxil-fumarateRenal function deterioration in the form of anuric renal failure, interstitial nephritis and end stage renal disease and off-label use: case report
Reactions Weekly, 2023, 1956 (1) : 116 - 116
[7] VITAMIN D3 SUPPLEMENTATION DOES NOT AFFECT SERUM LIPIDS IN NON-DIABETIC PATIENTS WITH MODERATE IMPAIRMENT OF RENAL FUNCTION
Dezfoolian, Hamid
Samuelsson, Ola
Svensson, Maria
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 403 - 403